Aquilo Capital Management, Llc - Net Worth and Insider Trading
Aquilo Capital Management, Llc Net Worth
The estimated net worth of Aquilo Capital Management, Llc is at least $5 Million dollars as of 2024-06-02. Aquilo Capital Management, Llc is the 10% Owner of Spero Therapeutics Inc and owns about 3,419,435 shares of Spero Therapeutics Inc (SPRO) stock worth over $5 Million. Aquilo Capital Management, Llc is also the 10% Owner of Pieris Pharmaceuticals Inc and owns about 45,944 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $466,332. Details can be seen in Aquilo Capital Management, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Aquilo Capital Management, Llc has not made any transactions after 2022-09-22 and currently still holds the listed stock(s).
Transaction Summary of Aquilo Capital Management, Llc
Aquilo Capital Management, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aquilo Capital Management, Llc owns 2 companies in total, including Spero Therapeutics Inc (SPRO) , and Pieris Pharmaceuticals Inc (PIRS) .
Click here to see the complete history of Aquilo Capital Management, Llc’s form 4 insider trades.
Insider Ownership Summary of Aquilo Capital Management, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2022-09-22 | 10 percent owner |
| PIRS | Pieris Pharmaceuticals Inc | 2020-07-21 | 10 percent owner |
Aquilo Capital Management, Llc Latest Holdings Summary
Aquilo Capital Management, Llc currently owns a total of 2 stocks. Among these stocks, Aquilo Capital Management, Llc owns 3,419,435 shares of Spero Therapeutics Inc (SPRO) as of September 22, 2022, with a value of $5 Million and a weighting of 91.24%. Aquilo Capital Management, Llc also owns 45,944 shares of Pieris Pharmaceuticals Inc (PIRS) as of July 21, 2020, with a value of $466,332 and a weighting of 8.76%.
Latest Holdings of Aquilo Capital Management, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2022-09-22 | 3,419,435 | 1.42 | 4,855,598 |
| PIRS | Pieris Pharmaceuticals Inc | 2020-07-21 | 45,944 | 10.15 | 466,332 |
Holding Weightings of Aquilo Capital Management, Llc
Aquilo Capital Management, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Aquilo Capital Management, Llc has made a total of 19 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years, including 13 buys and 6 sells. The most-recent trade in Spero Therapeutics Inc is the sale of 1,901,796 shares on September 22, 2022, which brought Aquilo Capital Management, Llc around $4 Million.
According to the SEC Form 4 filings, Aquilo Capital Management, Llc has made a total of 1 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Pieris Pharmaceuticals Inc is the sale of 23,750 shares on July 21, 2020, which brought Aquilo Capital Management, Llc around $6 Million.
Insider Trading History of Aquilo Capital Management, Llc
- 1
Aquilo Capital Management, Llc Trading Performance
GuruFocus tracks the stock performance after each of Aquilo Capital Management, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aquilo Capital Management, Llc is -40.83%. GuruFocus also compares Aquilo Capital Management, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aquilo Capital Management, Llc within 3 months outperforms 0 times out of 13 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aquilo Capital Management, Llc's insider trading performs compared to the benchmark.
Performance of Aquilo Capital Management, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.7 | | | | | |
| Relative Return to S&P 500(%) | -15.55 | | | | | |
Aquilo Capital Management, Llc Ownership Network
Aquilo Capital Management, Llc Owned Company Details
What does Spero Therapeutics Inc do?
Who are the key executives at Spero Therapeutics Inc?
Aquilo Capital Management, Llc is the 10 percent owner of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Financial Officer Sath Shukla , Chief Medical Officer Kamal Hamed , and Chief Development Officer Timothy Keutzer .
Spero Therapeutics Inc (SPRO) Insider Trades Summary
Over the past 18 months, Aquilo Capital Management, Llc made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 91,515 shares made by Sath Shukla , a net sale of 85,121 shares made by Ankit Mahadevia , and a net sale of 36,219 shares made by Timothy Keutzer .
In summary, during the past 3 months, insiders sold 0 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 316,580 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,580 shares.
Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spero Therapeutics Inc Insider Transactions
Aquilo Capital Management, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Aquilo Capital Management, Llc. You might contact Aquilo Capital Management, Llc via mailing address: One Letterman Drive, Suite D4900, Building D, San Francisco Ca 94129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
